Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
How do you approach isolated hip arthropathy with chondral loss in the setting of a moderately positive rheumatoid factor?
Related Questions
When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
Do you recommend Vitamin D and omega 3 fatty acid supplementation for prevention of autoimmune disease?
What is your approach to patients with severe sicca symptoms and history of B Cell lymphoma?
Does hepatitis B vaccination reduce the risk of HBV reactivation associated with immunosuppressive therapy?
What isolation policies are Rheumatology offices employing for both staff and patients diagnosed with COVID-19 given the new CDC guidelines?
Have you utilized combination biologic therapy for the treatment of rheumatic diseases?
How would you manage tubulointerstitial nephritis and renal tubular acidosis (RTA) in a patient with Sjogren's who is pregnant?
In patients with history of anaphylaxis to a TNF inhibitor, are you comfortable trying an alternative TNF inhibitor?
In a patient with active spondylarthritis and uveitis who cannot take TNF inhibitors, what is your next agent of choice?
How do you approach work up for underlying rheumatologic disease in patients referred for chronic urticaria?